Mammographic breast density and risk of contralateral breast cancer in kaiser permanente washington health research institute

Ended Purchase Order Awarded Last action

Contract number
75N91019P00245
Awardee
Awarding agency
Obligated
$149,765

Award facts

Opportunity
Contract value 100% obligated
$149,765.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
621511 Medical Laboratories
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Oakland, CA 94612, USA

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute awarded a purchase order to Kaiser Foundation Hospitals for $149,765.00 on May 10, 2019, to conduct research on mammographic breast density and risk of contralateral breast cancer at the Kaiser Foundation Research Institute in Oakland, California. The firm fixed price order has an ultimate completion date of May 19, 2020. The study originated from a pre-solicitation opportunity posted January 28, 2019, with a due date of February 11, 2019.

Quick answers

Who was awarded contract 75N91019P00245?

75N91019P00245 was awarded to Kaiser Foundation Hospitals by National Cancer Institute (National Institutes of Health) on May 10, 2019.

How much is contract 75N91019P00245 worth?

The government has obligated $149,765 on 75N91019P00245.

Was contract 75N91019P00245 competed?

The extent of competition for 75N91019P00245 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award